Nectar Lifesciences Ltd - 532649 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We are furnishing herewith newspaper cuttings of Financial Results of the Company for the period ended on March 31, 2019, which have been published in the following newspapers: 1. Business Standard (English-all editions) 2. Desh Sewak (Punjabi) NECTAR LIFESCIENCES LTD. - 532649 - Board recommends Final Dividend
Nectar Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 25, 2019, inter alia, have recommended the 5% Final Dividend i.e. Re. 0.05/- per equity share to the members of the Company, out of profits of the Company for the financial year 2018-2019, subject to the approval of the members in their Annual GeneralMeeting. NECTAR LIFESCIENCES LTD. - 532649 - Outcome of Board Meeting
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in their meeting held on May 25, 2019 have recommended the 5% Final Dividend i.e. Re. 0.05/- per equity share to the members of the company, out of profits of the company for the financial year 2018-2019, subject to the approval of the members in their Annual General Meeting. NECTAR LIFESCIENCES LTD. - 532649 - Audited Financial Results For The Year Ended On March 31, 2019
Please find enclosed herewith a copy of the Audited Financial Results (Standalone and Consolidated) for the period ended on March 31, 2019, as approved by the Board of Directors in their meeting held on even dated i.e. May 25, 2019. A copy of the Auditor's Report is also enclosed herewith for your record please. The declaration that audit reports do not contain any modified opinion is also attached NECTAR LIFESCIENCES LTD. - 532649 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We are furnishing herewith newspaper cutting of Notice of Board Meeting of the company scheduled to be held on May 25, 2019 which has been published in the following newspapers: 1. Business Standard (English-all editions) dated 20.05.2019. 2. Desh Sewak (Punjabi)dated 20.05.2019 NECTAR LIFESCIENCES LTD. - 532649 - Board Meeting Intimation for Audited Financial Results And Recommendation Of Dividend
NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2019 ,inter alia, to consider and approve 1. The Audited Financial Results for the Financial Year 2018-19, Financial Statements of the Company for the Financial Year 2018-19 and matters related thereto. 2. Recommendation of final dividend to the Members of the company for Financial Year 2018-19. Nectar Lifesciences Ltd - 532649 - Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period for which the report has been issued 31/03/2019 2Date of Report14/05/2019 3 Name of the Certifying Firm P. Chadha & Associates 4 Name of the Certifying Individual Prince Chadha 5Membership TypeACS 6 Membership Number 32856 7 CP No. 12409 8 Whether any observations/qualification reported by the Secretarial Auditor ? NO NECTAR LIFESCIENCES LTD. - 532649 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayNECTAR LIFESCIENCES LTD. 2CININE023H01027 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 266 4Highest Credit Rating during the previous FY A 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)BRICKWORK RATINGS INDIA PRIVATE LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkNSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: MS. ANKITA JAIN Designation: COMPANY SECRETARY EmailId: [email protected] Name of the Chief Financial Officer: MR. SANDEEP GOEL Designation: Chief Financial Officer EmailId: [email protected] Date: 23/04/2019 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. NECTAR LIFESCIENCES LTD. - 532649 - Shareholding for the Period Ended March 31, 2019
Nectar Lifesciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click here